Loading
Latest filing published 23 Jan 2020 for BetterLife Pharma Inc., €1,297.
No signal scores available.
Only one filing by James Russell Starr is known so far (23 January 2020): an open-market purchase, €1,297, in BetterLife Pharma Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration